Abstract. Infantile Mediterranean visceral leishmaniasis (IVL) and anthroponotic cutaneous leishmaniasis (ACL) have long been known to exist in the western and southeastern Turkey, respectively. To further study these and other related diseases, a recombinant antigen (rK39) specific to VL was used in an ELISA for serodiagnosis of selected patients and for screening dog reservoir populations in several endemic sites. Among 24 confirmed VL cases from western Turkey, the rK39 ELISA proved to be more sensitive than a combination of cultivation and microscopy of bone marrow aspirates. The specificity of rK39 for leishmaniasis was demonstrated by its lack of cross-reactivity with sera from other human diseases in the same sites. Interestingly, six of the 83 parasitologically proven ACL cases from southeast Turkey were also rK39 positive. The end point titers of the positive VL and CL cases vary from 10
Ϫ2
to 10 Ϫ5 and from 10 Ϫ2 to 10 Ϫ3 , respectively. The rK39 ELISA was also used to screen 494 apparently healthy dogs from Urfa in southeast Turkey, Manisa/Alasehir near the Aegean Sea, and Karabuk near the Black Sea. Eighteen rK39-positive cases (3.6%), all from the latter two areas, were found to have varying endpoint titers (10 Ϫ2 -10 Ϫ4 ). The high titers predicted increased severity and frequency of the clinical symptoms (i.e., lymphadenopathy, depilation, skin lesion, weight loss and/or death), which were manifested subsequently in 16 of these 18 cases. In addition, more positive canine cases were diagnosed by the rK39 ELISA preclinically than the procedures to detect parasites postsymptomatically in the lymph node aspirates. The use of the rK39 ELISA as a sensitive tool makes it possible to demonstrate coendemicity of canine and human VL, as expected in the case of IVL. The results also point to the possible presence of additional VL types in western Turkey and cutanovisceral type in the southeast part of this country.
Visceral leishmaniasis (VL) in the Old World includes several epidemiologic types, ranging from the classic anthroponosis of the Indian form to the zoonosis of infantile VL (IVL) common in the Mediterranean region. At the crossroads between the two continents, Turkey represents a geographic site of special interest because various forms of leishmaniasis have been reported in the surrounding regions, namely Caucasus, Asia Minor, the Mediterranean basin, and the Balkans (Figure 1 ).
One feature of IVL is that the infection rate may reach a level as high as 40% among the dog populations, with very few human cases. 1, 2 This is the type expected from the sporadic cases seen on the Aegean and Mediterranean coastal regions of Turkey. [3] [4] [5] [6] The VL cases in western Turkey have been sporadically reported, i.e., only 45 from 1954 to 1964 3 and 74 from 1974 to 1980. 4 The majority of VL cases seen during the last five years are from Manisa/Alasehir in the Aegean region. The parasites isolated from patients and dogs resemble Leishmania infantum. 6 Self-healing anthroponotic cutaneous leishmaniasis (ACL) is highly endemic in southeastern Turkey. 5 The causative agents are thought to be L. tropica and/or L. major. 6 Members of the former species have been reported to visceralize in other places. 7, 8 These and other related species have long been known to cause CL and VL in neighboring countries, e.g., Bulgaria, Greece, Iraq, Syria, Iran, and Georgia. 1, [8] [9] [10] The possible involvement of L. tropica and other potentially visceralizing species in the VL cases remains to be studied in Turkey. The recent epidemic outbreaks of ACL in Urfa brought to our attention this possibility for consideration. 11 Diagnosis of leishmaniasis in humans and reservoirs is crucial for controlling the disease and understanding its epidemiology. The classic methods based on the clinical symptoms and direct visualization of the parasites have been gradually replaced by more sensitive and less invasive procedures, e.g., serodiagnosis. [12] [13] [14] [15] One recombinant antigen suitable for VL is the rK39, a repetitive immunodominant epitope in a kinesin-related protein that is expressed predominantly in amastigotes and highly conserved among visceral Leishmania spp. 16 It has been demonstrated in a number of endemic sites that the rK39 ELISA is sensitive and specific for serodiagnosis and prognosis of human VL [16] [17] [18] [19] and to a lesser extent, canine VL. 16 Here, we report the successful identification of 18 cases of canine VL by screening 494 dogs with the rK39 ELISA and confirm its value in the diagnosis of human VL in western Turkey. Circumstantial evidence obtained also suggests the existence of other leishmaniasis types in addition to IVL and ACL.
MATERIALS AND METHODS
Sample collections and examinations. Serum samples were collected from patients and dog populations, and their respective control groups from 1993 to 1996. Patients were those referred during this period to various regional hospitals and diagnosed by experienced physicians to have the following clinical signs: fever, pancytopenia, anemia, splenomegaly, hepatomegaly, hepatosplenomegaly, and/or weaknesses ( Table 1) . These clinical signs are consistent with human VL. Household dogs with identifiable owners were surveyed in the areas where human VL cases were reported. Lymphadenopathy was noted in some cases at the time of the survey; in follow-up studies, many were found to have subsequently developed more severe symptoms, such as depilation, skin lesions, and death ( Table 2 ). The clinical subjects and their controls are representatives of the true incidence L  11  12  13  14  15   10  2  3  15 4
* Demonstration of parasites in lymph node aspirates by microscopy after Giemsa staining (Smear) and by cultivation in NNN medium (Culture).
† L ϭ lymphadenopathy; De ϭ depilation; W ϭ weight loss; SL ϭ skin lesion; D ϭ death; -ϭ negative. † HS ϭ hepatosplenomegaly; P ϭ pancytopenia; F ϭ fever; S ϭ splenomegaly; A ϭ anemia; W ϭ weakness; H ϭ hepatomegaly.
in so far as is known on the basis of previous epidemiologic and parasitologic studies.
Samples were collected from VL-or CL-endemic sites ( Bone marrow and lymph node aspirates were obtained from patients and dogs, respectively, for culture in rabbit whole blood agar (NNN medium) and for direct observations by microscopy after staining with Giemsa. Dogs were bled from the brachial veins and sera were stored at Ϫ80ЊC until use. Dogs were also examined physically for the signs of the disease, including enlargement of the popliteal lymph nodes.
The rK39-ELISA. Purified rK39 at a concentration of approximately 1 g/l in water was stored at Ϫ20ЊC.
16-19
Immulon-2 polystyrene microtiter plates (Dynatech, Chantilly, VA) were coated overnight with 20 ng of rK39/well in 50 l of 0.1 M bicarbonate buffer, pH 9.2 at 4ЊC. Plates were then blocked with 150 l of 1% bovine serum albumin for 1 hr and incubated with 50 l of serially diluted sera for 1 hr at 37ЊC. The wells were then washed three times with phosphate-buffered saline (PBS)/0.05% Tween 20 (PBSTween 20), and received 50 l of goat anti-human IgG conjugated with alkaline phosphatase (Sigma, St. Louis, MO) at a 10 Ϫ4 dilution and incubated at 37ЊC for 1 hr. The wells were then washed three times with PBS-Tween 20 and once with PBS, and samples were developed with 50 l of pnitrophenylphosphate (Sigma) in diethylamine buffer (pH 9) for 30 min. The optical density of each well was measured at 405 nm using an MR600 ELISA plate reader (Dynatech Products, Alexandria, VA). Values greater than the mean of negative controls plus three standard deviations were considered positive. All sera were initially tested at a 10 Ϫ2 dilution. End point titers of the positive samples were then determined. All samples were tested in duplicate and positive and negative controls were included in each plate. Dog sera were screened by the rK39-ELISA as described, except for the use of rabbit anti-dog IgG conjugated with horseradish peroxidase (Sigma) at a 10 Ϫ3 dilution and a 2, 2Ј-azino-bis(3-ethylbenz-thiozoline-6-sulfonic acid) (ABTS) tablet (one Sigma ABTS tablet in 100 ml of 0.03 M citrate- (24) and the total number of the subjects studied for each group are indicated in parentheses. CL ϭ cutaneous leishmaniasis; Toxo. ϭ toxoplasmosis; Non-end. Control ϭ apparently healthy subjects from a nonendemic region; End. Control ϭ apparently healthy subjects confirmed as negative for VL by culture and microscopy from the endemic sites; Av. OD ϭ the average optical density readings of each group. Bars show the arithmetic mean or average OD. 77 denotes the total number of rK39-negative cases. 
RESULTS

Human VL.
From 1993 to 1996, we encountered 71 subjects with clinical symptoms suggestive of VL. Forty-seven of these subjects were eventually found to have diseases other than VL. The remaining 24 were diagnosed as having VL by the positive results for least one of the three methods used. Bone marrow aspirates were microscopically positive for parasites in 21 cases, of which 16 were also culture positive ( Table 1 ). The rK39-ELISA confirmed all except one (patient # 24). Three smear-and culture-negative cases were rK39 seropositive (patients # 8, 13, and 16) ( Table 1 ). Antimonial chemotherapy was given to these 24 patients and resulted in the resolution of their clinical symptoms. Their diagnosis of VL was thus further confirmed, including the three cases diagnosed only by the rK39-ELISA. Among these 24 patients, the rK39-ELISA, microscopy, and culture gave positivity rates of 96%, 88%, and 33%, respectively (Table 1) . Thus, the ELISA is the most sensitive method. Eleven of the 24 VL cases were from Manisa and the rest were from other cities in western Turkey. The patients were all less than 13 years of age, except for three who were 16, 31, and 35 years old (Table 1 , patients # 5, 11, and 18) and from Denizli, Aydin, and Izmir, respectively (Figure 1) .
The rK39-ELISA was found to be highly specific for VL in Turkey (Figure 3) . At a 10 Ϫ2 serum dilution, most CL patients and all the control groups gave little or no reaction, including patients with toxoplasmosis and malaria, as well as apparently healthy persons from endemic and nonendemic regions (Figure 3) . One sample among the malaria group gave a marginally positive reaction (see Discussion for explanation). All except six (7%) (Figure 3 ) serum samples from 83 parasitologically diagnosed CL patients were rK39-negative, as observed previously 17 (see Discussion). The end point titer of some VL patients reached a very high level (Ͼ10 Ϫ5 ), whereas titers of the six positive CL cases never exceeded 10 Ϫ3 (Figure 4) . The end point titers of VL patients varied considerably among different samples, ranging from 10 Ϫ2 to 10 Ϫ5 (Figure 4 and Table 1 ). Canine VL. Apparently healthy dogs were surveyed by the rK39 ELISA in the VL-or CL-endemic areas of Manisa/ Alasehir, Karabuk, and Urfa, but were surveyed more thoroughly in the first location and its surrounding areas ( Figure  1, rectangular frames) . Of the 24 villages more thoroughly FIGURE 5 . Specificity of the rK39 ELISA for canine visceral leishmaniasis (VL). See Materials and Methods for experimental details. All the control groups are from Turkey. The 19 positive dogs of 494 examined for VL and the total number for each of the other groups are presented in parentheses. VL Endemic Control ϭ apparently healthy dogs from the endemic sites, as confirmed by microscopy and culture; Non Endemic Control ϭ apparently healthy dogs from a nonendemic region; CL Endemic Control ϭ dogs from Urfa, which is highly endemic for cutaneous leishmaniasis (CL), confirmed as negative for VL by microscopy, and culture; Av. OD ϭ the average optical density readings of each group. Bars show the the average OD.
surveyed, 22 were near Manisa ( Figure 2 ) and two were near Alasehir (Figure 2) , covering a total population of 18,827 and 676, respectively, according to the 1990 census. The population of children in the 24 villages was approximately 4,000, as calculated from the adult:children ratio provided by the census bureau. A total of 494 dogs were examined, representing approximately 35% of the estimated total dog population. Eighteen were rK39-positive (3.6%) at a 10 Ϫ2 serum dilution; the control groups were all negative or marginally reactive ( Figure 5 ). However, one rK39-negative case ( Figure 5 ) was microscopically parasite positive (dog # 19) ( Table 2) , making the total number of positive cases 19. Initial physical examinations of these dogs revealed no obvious signs of VL, except a minimal popliteal lymphadenopathy in some cases. There were more males (89%) than females (11%) among the seropositive dog population. The infection rates were 4.23% (17 of 402) and 2.17% (2 of 92) for males and females, respectively, but this difference was not statistically significant ( 2 ϭ 0.8544, P Ͼ 0.03). The rK39-seropositive rates were 3.6-8.7% in four of the 22 villages near Manisa (Figure 2 ), but they reached high levels of 9.5-19% in the two villages near Alasehir (Figure 2) . Previously, VL patients were reported in two of the six positive villages, i.e., Kale and Kozluca, but also in Manisa city (Figure 2) . Similarly, in Nebioglu village (population ϭ 33) near Karabuk (Figure 1 ), 25 dogs surveyed gave an rK39-positive rate of 8%. The 25 dogs from the CL-epidemic area of Urfa were all negative, consistent with the finding of no parasites by microscopy and culture of their lymph node aspirates.
Further studies of the 19 positive dogs showed that the rK39 ELISA, microscopy, and culture gave positivity rates of 95%, 74%, and 53%, respectively ( Table 2 ). The end point titers of the seropositive dogs for rK39 varied considerably from 10 Ϫ2 to 1.3 ϫ 10 Ϫ4 ( Table 2 ). The rK39 ELISA is nevertheless more sensitive and specific than other means of diagnosis for canine VL. Five dogs were rK39 ELISA positive, but microscopy and culture negative ( Table 2, dogs # 11, 13, and 16-18) . Three of these five dogs with the lowest rK39 titers (Dogs # [16] [17] [18] were also positive by a Leishmania-specific polymerase chain reaction assay. Taken together, a total of 19 canine cases were confirmed by one of the above-mentioned methods.
Screening of the dog populations by the rK39 ELISA made it possible to focus our attention to a limited number of the positive cases. The 18 seropositive dogs in the Manisa area were followed-up. Subsequent examinations of these dogs revealed that 16 showed advanced lymphadenopathy and six developed depilation, weight loss, and/or skin lesions. After one year, two of these dogs died. These clinical signs were generally correlated with high rK39 ELISA end point titers (Table 2) .
DISCUSSION
The results obtained from this work on the diagnosis of VL add to our understanding of its epidemiology in western Turkey (Figure 1 ). The data indicate that the rK39 ELISA is a sensitive and specific method of diagnosis for both human and canine VL, giving a positivity of 95-96% and compares very favorably with the conventional methods (Tables 1 and 2 ). In several culture-and microscopy-negative cases, rK39 positivity was corroborated with the results of other sensitive methods of diagnosis. [20] [21] [22] [23] The rK39-ELISA gave negative results in all the control groups (Figures 3 and 5) , except the marginal reading with a malaria patient at a serum dilution of 10
Ϫ2
. Undiagnosed VL concurrent with malaria may explain this marginally positive case, as found previously. 18 Notably, the rK39 ELISA gives specific reaction at a 10 Ϫ2 serum dilution (Figure 3) , which often produces nonspecific reactions with the most commonly used ELISA antigen, i.e., whole promastigote lysates. [24] [25] [26] [27] [28] [29] [30] [31] It is well-known that such impure antigens notoriously lack specificity, especially for canine leishmaniasis. 2 Previous attempts to improve the sensitivity and specificity of serologic tests also have relied on the use of recombinant or purified antigens, 32, 33 such as gp63, 17,34 dp72, and gp70. 26, 35 The findings presented here lend credence to the conclusions for the sensitivity and specificity of the rK39 ELISA reached from our previous work in Brazil, China, India and Pakistan. [16] [17] [18] [19] In our survey of 494 dogs in the VL-endemic regions, the rK39 positive rates were as high as 3.6-19% among the six villages surrounding Manisa/Alasehir ( Figure 2 ) and 8% in Nebioglu near Karabuk. Only sporadic human VL cases have been reported in these places. This is the typical picture of IVL in the Mediterranean region. 1,2 Our survey unintentionally included more males than females (402 versus 19), obviously accounting for the sexual bias seen (Table 2) . Indeed, no sexual difference in the susceptibility of dog to VL was noted previously. 14, 27, 29 The clinical picture of canine VL follows a progressive course with increasing anti-Leishmania antibody titers. 36 Of interest in the case of anti-rK39 antibodies is that these titers apparently increase without or before manifestations of overt clinical symptoms in these dogs ( Table 2 ). The high anti-rK39 antibody titers are nevertheless predictive of the severity of the clinical symptoms developed subsequently, as found previously in human VL elsewhere. 18, 19 Interestingly, the villages with seropositive dogs are not tightly clustered ( Figure 2 ) and VL patients emerge in the urban area of Manisa where dogs are very rare (Figure 2 ). This dispersal of the human VL cases results presumably from traveling patients during the sandfly season, since the mobility of dogs is limited to the rural villages.
The work presented also suggests the possible presence of other clinicoepidemiologic types of VL in Turkey. First, not all of the VL cases we studied were limited to young children, a hallmark of the Mediterranean type. Although 21 of the 24 patients were 13 years old or younger (Table 1) and from Manisa and Karabuk, areas coendemic with canine VL, the remaining three were adults from other cities, i.e., Izmir, Aydin, and Denizli. These cases may represent a new entity, although further studies of additional samples are needed to eliminate the possibility of imported or atypical cases. In addition, we confirmed our previous observations 17 by finding six rK39-positive patients among the 83 CL (7.2%) patients, mainly from Urfa. More significantly, their sera were found in this study to contain significant titers of anti-rK39, i.e., up to 10 Ϫ3 (Figures 3 and 4) . Previous findings of no detectable anti-rK39 antibody response in South American CL 16 raises the possibility that these Turkish CL patients may be infected with a visceralizing strain of cutaneous Leishmania. Further investigation of the parasites, sandfly vectors, and reservoirs are essential to fully understand the heterogeneity of leishmaniasis in Turkey.
